-
SIOX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Sio Gene Therapies (SIOX)
Company Profile
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 46.13 mm | 46.13 mm | 46.13 mm | 46.13 mm | 46.13 mm | 46.13 mm |
Cash burn (monthly) | 1.64 mm | 3.08 mm | 1.34 mm | 2.38 mm | 1.64 mm | 3.04 mm |
Cash used (since last report) | 42.76 mm | 80.29 mm | 34.92 mm | 62.00 mm | 42.76 mm | 79.30 mm |
Cash remaining | 3.36 mm | -34.16 mm | 11.21 mm | -15.87 mm | 3.36 mm | -33.17 mm |
Runway (months of cash) | 2.1 | -11.1 | 8.4 | -6.7 | 2.1 | -10.9 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Proequities | 0.00 | $0.00 |